CINV — Crucial Innovations Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Crucial Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st  | R2019 December 31st  | 2020 December 31st  | 2021 December 31st  | 2022 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Net Income/Starting Line | -0.015 | -0.046 | -0.031 | -0.023 | -0.114 | 
| Depreciation | |||||
| Non-Cash Items | — | 0 | 0.012 | — | 0.071 | 
| Unusual Items | |||||
| Changes in Working Capital | 0.028 | 0.01 | 0.013 | -0.001 | 0.043 | 
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 0.013 | -0.034 | -0.006 | -0.024 | 0 | 
| Capital Expenditures | -0.014 | — | — | — | — | 
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.014 | — | — | — | — | 
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.001 | 0.034 | 0.006 | 0.024 | 0 | 
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.001 | -0.001 | 0 | 0 | 0 |